Bicara Therapeutics Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCAX research report →
About the company
Bicara Therapeutics Inc. , a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors.
- CEO
- Claire Mazumdar Clemon
- IPO
- 2024
- Employees
- 55
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $1.59B
- P/E
- -11.19
- P/S
- 0.00
- P/B
- 3.43
- EV/EBITDA
- -8.07
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -35.89%
- ROIC
- -33.77%
- Revenue
- $0 · 0.00%
- Net Income
- $-137,950,000 · -102.88%
- EPS
- $-2.52 · -101.60%
- Op Income
- $-155,604,000
- FCF YoY
- -43.16%
- 52W High
- $29.90
- 52W Low
- $8.74
- 50D MA
- $22.59
- 200D MA
- $18.56
- Beta
- -0.81
- Avg Volume
- 667.55K
Get TickerSpark's AI analysis on BCAX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 9, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 19,475 |
| Jun 9, 26 | Bowden Christopher | other | 19,475 |
| Jun 9, 26 | Haviland Kate | other | 19,475 |
| Jun 9, 26 | Mazumdar-Shaw Kiran | other | 19,475 |
| Jun 9, 26 | Robertson Scott M. | other | 19,475 |
| Jun 9, 26 | POWELL MICHAEL | other | 19,475 |
| Jun 9, 26 | Simson Jake | other | 19,475 |
| May 21, 26 | Hyep Ivan | other | 9,200 |
| May 21, 26 | Hyep Ivan | sell | 9,200 |
| May 21, 26 | Hyep Ivan | other | 9,200 |
Our BCAX coverage
Recent articles, reports, and earnings notes.
No research on BCAX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BCAX report →Similar companies
Peers in the same neighborhood.